Jeffrey Eisele - 22 Dec 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Exec VP, Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Issuer symbol
APLS
Transactions as of
22 Dec 2021
Net transactions value
-$4,256
Form type
4
Filing time
23 Dec 2021, 15:49:03 UTC
Next filing
25 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $4,256 -89 -1.2% $47.82 7,372 22 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.